These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12675715)

  • 1. CMV DNA is rarely detected in healthy blood donors using validated PCR assays.
    Roback JD; Drew WL; Laycock ME; Todd D; Hillyer CD; Busch MP
    Transfusion; 2003 Mar; 43(3):314-21. PubMed ID: 12675715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors.
    Roback JD; Hillyer CD; Drew WL; Laycock ME; Luka J; Mocarski ES; Slobedman B; Smith JW; Soderberg-Naucler C; Todd DS; Woxenius S; Busch MP
    Transfusion; 2001 Oct; 41(10):1249-57. PubMed ID: 11606824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time.
    Larsson S; Söderberg-Nauclér C; Wang FZ; Möller E
    Transfusion; 1998 Mar; 38(3):271-8. PubMed ID: 9563407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.
    Drew WL; Tegtmeier G; Alter HJ; Laycock ME; Miner RC; Busch MP
    Transfusion; 2003 Mar; 43(3):309-13. PubMed ID: 12675714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
    Ziemann M; Juhl D; Görg S; Hennig H
    Transfusion; 2013 Oct; 53(10):2183-9. PubMed ID: 23581526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytomegalovirus polymerase chain reaction and serology for screening umbilical cord blood components.
    Roback JD; Caliendo AM; Newman JL; Sgan SL; Saakadze N; Gillespie TW; Lane TA; Kurtzberg J; Hillyer CD
    Transfusion; 2005 Nov; 45(11):1722-8. PubMed ID: 16271096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
    Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
    Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction.
    Bitsch A; Kirchner H; Dupke R; Bein G
    Transfusion; 1992 Sep; 32(7):612-7. PubMed ID: 1325693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.
    Ziemann M; Juhl D; Brockmann C; Görg S; Hennig H
    Transfusion; 2017 Jul; 57(7):1691-1698. PubMed ID: 28370032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
    Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
    Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
    Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C
    Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology.
    Krajden M; Shankaran P; Bourke C; Lau W
    J Clin Microbiol; 1996 Jan; 34(1):29-33. PubMed ID: 8748266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus DNA is not detectable with nested double polymerase chain reaction in healthy blood donors.
    Urushibara N; Kwon KW; Takahashi TA; Sekiguchi S
    Vox Sang; 1995; 68(1):9-14. PubMed ID: 7725678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cytomegalovirus in blood donors by the polymerase chain reaction.
    Smith KL; Kulski JK; Cobain T; Dunstan RA
    Transfusion; 1993 Jun; 33(6):497-503. PubMed ID: 8390729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
    Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
    BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.